Septagen addresses the hidden health risks associated with perimenopause, a transitional period often overlooked in women's healthcare. The company provides solutions designed to identify and manage the subtle physiological changes that occur during this phase, which are frequently missed by standard medical practice. Their approach focuses on proactive detection and management of these emerging health concerns.
Funding
Funding not disclosed
Founders
Product
Problem
Perimenopause, the transition leading to menopause, introduces significant hormonal shifts that can increase a woman's risk for long-term health issues, yet these risks often go undetected and unaddressed in standard medical care. This hidden risk period is frequently overlooked, leaving women without proactive screening or management strategies for conditions that may be developing.
Solution
Septagen provides a solution focused on identifying and addressing the hidden health risks associated with the perimenopausal transition. The company's platform is designed to bring attention to the specific physiological changes and potential health concerns that emerge during this phase of life. By focusing on this often-ignored period, Septagen aims to enable earlier intervention and more personalized healthcare strategies for women, moving beyond the traditional reactive model of care.
Target Audience
The primary audience includes women in the perimenopausal age range and healthcare providers seeking a more comprehensive framework for managing their patients' evolving health needs during this transition.
Features
- Specialized focus on the perimenopausal transition as a distinct and critical health phase
- Tools or services designed to identify and assess health risks that are commonly overlooked during this period
- A proactive approach to women's health, emphasizing early detection and management
- Solutions that bridge the gap between standard gynecological care and the long-term health issues associated with hormonal changes